Eris Lifesciences has informed that a meeting of the Board of Directors of Eris Lifesciences (the Company) is scheduled on Tuesday, February 04, 2025, to, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and nine months ended December 31, 2024. Further, as informed vide letter dated December 24, 2024, the trading window has been already closed from January 01, 2025, and will remain closed till 48 hours after the declaration of financial results of the Company pursuant to SEBI [Prohibition of Insider Trading] Regulations, 2015, and Policy on ‘Code of Conduct to Regulate, Monitor and Report Trading by its Designated Persons and immediate relatives of Designated Persons of the Company’ for the purpose of Board Meeting.
The above information is a part of company’s filings submitted to BSE.
